Solid Biosciences (SLDB) EBT Margin (2022)
Solid Biosciences (SLDB) recorded EBT Margin of -1282.88% in FY2022, down 752.85 percentage points from -530.03% in FY2021.
Powered by 
Analysis
Solid Biosciences (SLDB) EBT Margin (2022) Analysis & Trends
- Per Business Quant data, SLDB's EBT Margin was -530.03% in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | -4.34% |
| 10 | Solid Biosciences | 931.82 Mn | -250.53 Mn | - | - |
API Access
Solid Biosciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();